Indivior (LON:INDV) Stock Price Down 17% – What’s Next?

Indivior PLC (LON:INDV)’s share price was down 17% during mid-day trading on Thursday . The stock traded as low as GBX 548.71 ($6.90) and last traded at GBX 720.60 ($9.07). Approximately 2,904,792 shares traded hands during trading, an increase of 294% from the average daily volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.65) price objective on shares of Indivior in a report on Tuesday, December 17th.

Indivior Price Performance

The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The stock has a market capitalization of £1.13 billion, a P/E ratio of -597.48, a PEG ratio of -5.57 and a beta of 0.19. The stock’s fifty day moving average is GBX 928.06 and its 200-day moving average is GBX 853.71.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.